Blood Glucose Determinations Research Articles

Nutrition and Micronutrient Therapy in Critical Illness Should Be Individualized.

Critically ill (intensive care unit [ICU]) patients are characterized by organ failure, intense inflammatory response, insulin resistance, and altered metabolic response. The sicker the patient, the higher the threat to nutrition and micronutrient status. In addition, many patients start the ICU stay with an altered nutrition status, which requires assessment upon admission. Nutrition needs vary among patients as well as during hospitalization, as the metabolic response changes over time. Shock and acute organ failure result in a metabolic shift toward intense catabolism: endogenous glucose production aiming at ensuring the basal adenosine triphosphate production starts immediately and occurs at the expense of the lean body mass using amino acids for neoglucogenesis. Later, the stabilization and recovery phases are characterized by higher energy and substrate needs. Indirect calorimetry is the only tool enabling determination of the metabolic level. When and how should feeding be started? Recent research shows that the route does not matter much, with equipoise between enteral and parenteral nutrition (PN) as long as overfeeding is avoided. As micronutrients are an integral part of metabolism and antioxidant defenses, their delivery must be ensured: whereas needs are well defined for healthy individuals, needs for illness remain poorly defined. PN that contains only macrosubstrates requires the daily prescription of multimicronutrient complements to qualify as total PN. Achievement of goals requires minimal monitoring, consisting of the daily verification of energy and protein goal delivery achievement and daily follow-up determining blood glucose and phosphate levels and insulin requirements.

A Hybrid Redox-Active Polymer Based on Bovine Serum Albumin, Ferrocene, Carboxylated Carbon Nanotubes, and Glucose Oxidase

We used conducting redox-active polymers based on chitosan and bovine serum albumin (BSA), covalently bound to mediators ferrocene or Neutral Red, or thionine, modified by carbon nanotubes, as a base of an amperometric biosensor for determining glucose. The structure of the obtained polymers was studied by IR spectroscopy and scanning electron microscopy. Their electrochemical characteristics were studied by cyclic voltammetry. The redox-active polymer based on BSA covalently bound to ferrocene and modified by carboxylated carbon nanotubes demonstrated the most promising characteristics. The biosensor based on the selected hybrid polymer is characterized by high sensitivity, a lower limit of determined concentrations of 0.05 mM, and a high correlation coefficient (R = 0.9919) with the results of determination of glucose in human blood by an alternative method.

Association between non alcoholic fatty liver disease, metabolic and vascular risk

BackgroundHepatic steatosis is a public health problem with increased incidence and prevalence ObjectiveTo determine whether the liver steatosis, as measured by the Fatty Liver Index (FLI), is related to metabolic risk and vascular factors and, if so, to identify the clinical-metabolic factor that explains the higher vascular risk. MethodsCross-sectional study including a sample of 531 men who came to the University of Navarra Clinic Check-up Unit. The degree of steatosis was determined by the FLI. The metabolic risk was assessed using a scale based on determinations of HDL, LDL, triglycerides, blood glucose, HOMA-IR, neutrophil/lymphocyte index, and systolic blood pressure. The vascular risk was assessed by the presence of carotid and/or femoral atheromatous plaques. The dose-response association between FLI and both risks was analysed using non-parametric models (splines) and logistic regression. ResultsThe sample studied had a mean age of 52.70 years, with 49.3% having an FLI ≥ 60, as well as 33.6% with metabolic syndrome, and 43.9% with carotid and/or femoral atheromatous plaques. The relationship between FLI and metabolic risk and vascular was linear (Metabolic: non-linear P = .097; linear P < .001; Vascular: non-linear P = 1.000; linear P = .028). For every 10 units of increase in FLI, the odds of presenting with atheroma plaques increased by 9.7% (OR=1.097; 95% confidence interval 1.010–1.191). When adjusting for triglyceridaemia, the association disappeared (OR=1.001). ConclusionsPatients with fatty liver disease had an increased metabolic and vascular risk. The increased vascular risk is associated with the triglyceride level. On a clinical level, this study suggests that these patients could benefit from treatment of hypertriglyceridaemia.

Non‐invasive Measurement of Blood Glucose by Breath Analysis

The determination of blood glucose is usually performed in the laboratory or using invasive glucose meters. Unusual, fruity, or bad breath odor can be a sign of metabolic disease. The objective is the estimation of the blood glucose by breath analysis. To do that, we designed a three‐gas prediction model (alcohol, acetone, and propane). We exhaled in front of the three gas sensors and then recorded the concentrations of the three volatile organic compounds (VOCs) in a database. This database included the measurements of 200 volunteer people. We then systematically studied the correlation between the glucose level obtained by blood analysis and each of these three gases. We also studied the different possible combinations of two and three gases. The best correlation was obtained for the non‐diabetic subjects with a correlation coefficient (r = 0.97), for the diabetic subjects (r = 0.35). We implemented these two linear regressions and we used the validation set to estimate the accuracy of the prototype. For the non‐diabetic subjects, the relative error of the measurement of the glycemia was equal to 3.93%. For the diabetic subjects, the error = 13.42%. The results have shown that the determination of glycemia by breath analysis can become a serious alternative. © 2020 Institute of Electrical Engineers of Japan. Published by Wiley Periodicals LLC.

Effect of Addition of WZB117 as an Inhibitor of Glucose Transporter 1 for Venous Blood Glucose Determination.

Sodium fluoride (NaF) has been applied to inhibit glycolysis in venous specimens for decades. However, it has had little effect on the rate of glycolysis in the first 1 to 2 hours, resulting in a decrease of glucose, so a more efficient method is needed. Recently, we discovered that WZB117, a specific Glut1 inhibitor, restricts glycolysis by inhibiting the passive sugar transport of human red blood cells and cancer cells. The purpose of this study was to evaluate the results of intravenous blood glucose determination after the addition of WZB117. Venous specimens from 40 pairs of healthy volunteers were collected for several days and placed in tubes containing NaF plus EDTA-disodium (Na2) without WZB117 (the A group); citric acid, trisodium citrate, and EDTA-Na2 without WZB117 (B group); and NaF plus EDTA-Na2 with WZB117 (C group). The glucose concentration was measured after venipuncture and compared with test tubes treated for 1 hour, 2 hours, and 3 hours before centrifugation. Glucose level was determined by the hexokinase method. The paired t-test was used to examine differences in glucose values at baseline and at different time points. The number of misdiagnoses and the misdiagnosis rate were calculated at 2 diagnostic stages: high risk of diabetes (glucose level of 6.1 mmol/L) and diagnosis of diabetes (glucose level of 7.0 mmol/L). Glucose levels decreased by 1.0% at 1 hour and by 2.1% at 3 hours in the C group tubes and simultaneously decreased by 1.7% at 1 hour and by 2.5% at 3 hours in the B group tubes. In contrast, glucose levels decreased by 4.1% at 1 hour and by 6.3% at 3 hours in the A group tubes. There was a statistically significant difference in glucose levels measured in the A group tubes and B group tubes at 1 hour, 2 hours, and 3 hours. The misdiagnosis rate of clinical diagnosis in diabetes was highest in the A group tubes (7.0‰ at 1 hour, 0.1‰ at 3 hours at 7.0 mmol/L point; 14.6‰ at 1 hour, 0.4‰ at 3 hours at 6.1 mmol/L point) and lowest in the C group tubes (2.95‰ at 1 hour, 0‰ at 3 hours at 7.0 mmol/L point; 4.8‰ at 1 hour, 0.1‰ at 3 hours at 6.1 mmol/L point). The tube addition of WZB117 is more suitable for minimizing glycolysis and has no effect on glucose levels even if specimens are left uncentrifuged for up to 3 hours.

Optimization of Extraction Parameters of Reverse Iontophoretic Determination of Blood Glucose in an Artificial Skin Model

Background: Reverse İontophoresis (RI) is one of the promising non-invasive technologies. It relies on the transition of low magnitude current through the skin and thus glucose measurement becomes possible as it is extracted from the surface during this porter current flow. Objective: This paper deals with the development and optimization of an RI determination method for glucose. CE dialysis membrane based artificial skin model was developed and the dependence of RI extraction on various experimental parameters was investigated. Method: Dependence of RI extraction performance on noble electrodes (platinum, silver, palladium, ruthenium, rhodium) was checked with CA, CV and DPV, in a wide pH and ionic strength range. Optimizations on inter-electrode distance, potential type and magnitude, extraction time, gel type, membrane MWCO, usage frequency, pretreatment, artificial body fluids were performed. Results: According to the optimized results, the inter-electrode distance was 7.0 mm and silver was the optimum noble metal. Optimum pH and ionic strength were achieved with 0.05M PBS at pH 7.4. Higher glucose yields were obtained with DPV, while CA and CV achieved almost the same levels. During CA, +0.5V achieved the highest glucose yield and higher potential even caused a decrease. Glucose levels could be monitored for 24 hours. CMC gel was the optimum collection media. Pretreated CE membrane with 12kD MWCO was the artificial skin model. Pretreatment affected the yields while its condition caused no significant difference. Except PBS solution (simulated as artificial plasma), among the various artificial simulated body fluids, intestinal juice formulation (AI) and urine formulation U2 were the optimum extraction media, respectively. Conclusion: In this study, various experimental parameters (pretereatment procedure, type and MWCO values of membranes, inter-electrode distance, electrode material, extraction medium solvents, ionic strength and pH, collection medium gel type, extraction potential type and magnitude, extraction time and etc) were optimized for the non-invasive RI determination of glucose in a CE dialysis membrane-based artificial skin model and various simulated artificial body fluids.

Asociación entre hígado graso no alcohólico, riesgo metabólico y vascular

BackgroundHepatic steatosis is a public health problem with increased incidence and prevalence ObjectiveTo determine whether the liver steatosis, as measured by the Fatty Liver Index (FLI), is related to metabolic risk and vascular factors and, if so, to identify the clinical-metabolic factor that explains the higher vascular risk. MethodsCross-sectional study including a sample of 531 men who came to the University of Navarra Clinic Check-up Unit. The degree of steatosis was determined by the FLI. The metabolic risk was assessed using a scale based on determinations of HDL, LDL, triglycerides, blood glucose, HOMA-IR, neutrophil/lymphocyte index, and systolic blood pressure. The vascular risk was assessed by the presence of carotid and/or femoral atheromatous plaques. The dose-response association between FLI and both risks was analysed using non-parametric models (splines) and logistic regression. ResultsThe sample studied had a mean age of 52.70years, with 49.3% having an FLI ≥60, as well as 33.6% with metabolic syndrome, and 43.9% with carotid and/or femoral atheromatous plaques. The relationship between FLI and metabolic risk and vascular was linear (metabolic: non-linear P=.097; linear P<.001; vascular: non-linear P=1.000; linear P=.028). For every 10 units of increase in FLI, the odds of presenting with atheroma plaques increased by 9.7% (OR=1.097; 95% confidence interval 1.010-1.191). When adjusting for triglyceridaemia, the association disappeared (OR=1.001). ConclusionsPatients with fatty liver disease had an increased metabolic and vascular risk. The increased vascular risk is associated with the triglyceride level. On a clinical level, this study suggests that these patients could benefit from treatment of hypertriglyceridaemia.

Effect Of Wearing Lower-body Compression Garments During Prolonged Running On Substrate Oxidation And Running Kinematics

Lower body compression garments (CG) have been suggested previously to provide favorable effects during running. One of explanation for the benefits of wearing CG might be explained by augmented arterial blood flow by external pressure applied. Enhanced muscle perfusion can increase oxygen delivery to exercising muscle, thereby affecting oxygen uptake and substrate oxidation. Furthermore, wearing CG might assist the propulsive force by optimizing running kinematics as a result of the elastic nature of the garment, leading to less metabolic cost of running at a given speed. These insights may be advantageous in situation with prolonged running, which is required large metabolic demand under development of fatigue. However, little information is available for effect of wearing CG during prolonged running (> 1h) on energy metabolism and running kinematics. PURPOSE: To determine influence of wearing CG on energy metabolism and running kinematics during prolonged running. METHODS: Eight physical active male (24 ± 2 yrs, 168.4 ± 5.0 cm, 63.9 ± 5.0 kg, VO2max; 54.8 ± 4.3 mL·kg-1·min-1) completed 2 exercise trial in the different days. The exercise consisted of 120 min of uphill running (7% gradient) at 60 % of VO2max (6.8 ± 0.6 km·h-1). The exercise trials included 1) wearing CG with exerting 15 mmHg [CG]; and 2) wearing garment with exerting below 5 mmHg [CON] to thigh and calf. Respiratory gas variables (carbohydrate oxidation) and running kinematics (step length and frequency, ground-contact time, flight time, joint angles) were assessed every 30 min of exercise. Blood samples were collected to determine blood glucose and lactate, and plasma IL-6 as indication of carbohydrate metabolism. P < 0.05 was considered to be statistically significant. RESULTS: Time course of changes in carbohydrate oxidation, running kinematics and blood glucose and lactate did not differ between the two trials (P > 0.05). Area under the curve (AUC) of plasma IL-6 concentration for 120 min of exercise tended to be lower in the CG trial (803 ± 452 pg·mL-1) compared with in the CON trial (1,219 ± 842 pg·mL-1, P = 0.07). A positive relationship was observed between the AUC of plasma IL-6 concentration and the total carbohydrate oxidation (r = 0.5, P = 0.049). CONCLUSION: Wearing CG did not alter energy metabolism and running kinematics during prolonged running.

Hypoglycemic Activity and the Mechanisms of Lycium Bark Extract in db/db Mice.

The extract of Lycium bark (LBE), which is the root bark of Lycium chinense, has long been used in China for hypertension, inflammation, and diabetes. LBE has been reported to ameliorate hyperglycemia in mice with alloxan-induced type 1 diabetes, but evidence on the effect of LBE in diabetes had not been enough. Therefore, we investigated the effects of LBE on type 2 diabetes using db/db mice. Nine-week-old male db/db mice were orally administered LBE (425 mg/kg) for 10 weeks. Blood samples were collected under anesthesia for the determination of blood glucose and insulin levels. The blood glucose level was increased in the control group and was unchanged in the LBE group. The blood insulin level was increased in both groups within 4 weeks, but it decreased in the control group and was maintained at a relatively high level in the LBE group thereafter. Furthermore, LBE increased the glucose uptake, which was measured using C2C12 myotubes, in a concentration-dependent manner, independent of the addition of a phosphatidylinositol 3-kinase inhibitor (i.e., LY294002) and an AMP-activated kinase inhibitor (i.e., dorsomorphin). And LBE increased the mRNA expression of glucose transporter (GLUT) 1. These results suggested that LBE decreased the blood glucose level by additive effect such as improvement of the insulin secretion, promoting activity of glucose uptake. These findings suggested that LBE administration can be a novel therapeutic approach for type 2 diabetes.

Non-enzymatic sensor based on nitrogen-doped graphene modified with Pd nano-particles and NiAl layered double hydroxide for glucose determination in blood

Herein, a novel highly sensitive and selective non-enzymatic glucose sensor was developed. This sensor was prepared with a one-step electrodeposition process, which means that the palladium nanoparticles and NiAl layered double hydroxide were electrosynthesized simultaneously (Pd-NiAl-LDH) on a graphite sheet electrode (GS) covered by nitrogen-doped functionalized graphene (NFG). The sensing performance was investigated by linear sweep voltammetry (LSV), cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS) and chronoamperometry (CA) techniques. The results revealed that the one-step electrodeposition of Pd-NiAl-LDH nanocomposite on NFG provided a large surface area containing Ni and Pd electroactive centers and enhanced the electron transfer. This resulted in a remarkable effect on signal amplification toward glucose oxidation, with a wide linear range from 500 nM to 10 mM, an acceptable sensitivity of 315.46 μA. cm−2. dec−1 and a low detection limit of 234 nM based on a signal to noise ratio of 3. The relative standard deviation (RSD%) in all detection tests was lower than 5% and also the performance of fabricated GS/NFG/Pd-NiAl-LDH electrode which investigated in human real samples including serum, plasma and blood was acceptable, indicating the ability of the fabricated sensor in biological and clinical applications.

Micrometer-scale light-addressable potentiometric sensor on an optical fiber for biological glucose determination

A novel light-addressable potentiometric sensor (LAPS), on the micrometer scale, is presented for rapid determination of blood and urine glucose. A LAPS chip with <150 μm working diameter is fabricated using standard semiconductor technique, and assembled onto an optical fiber of a laser module to form a micro-sized device. An active circuit design, containing on-board light driver and transimpedance amplifier, is introduced to simplify electronic connection and improve signal quality. Glucose-sensitive layer is obtained by drop-coating glucose oxidase onto the working surface of the LAPS. Under optimized optical and electrochemical conditions, the proposed sensor is used to detect glucose in laboratorial and real samples. In a wide range as 0.01–100 mM, a log-linear relationship is well established, and the response time is less than 10 s. Limit of detection and limit of quantitation of this method are found to be 0.003 and 0.01 mM, respectively. Data from the proposed method are validated with those from a certified clinical analyzer, and no statistic difference is found.

Design of Automatic Insulin Dosage Indicator for Diabetic Patients Using BMI

Diabetes Mellitus is a serious and chronic health disease. It occurs in all age group of people, especially in adults and aged persons. It is important to measure blood glucose level frequently for the diabetes affected persons which in need to determine the appropriate insulin dosage. Along with this, the continuous glucose monitoring is vital to know whether the glucose level is in normal range. The conventional method used to measure the glucose level in blood is invasive which is infectious and a painful process. Nowadays, the non-invasive blood glucose monitoring methods are widely used. In this work, the blood glucose level is measured non-invasively using IR sensor. Besides that, the indication of insulin dosage to be taken is done by determining blood glucose concentration (non- invasively) and comparing it with Body Mass Index (BMI) of the patient. The implementation is based on the variations in the intensity of the IR LED, BMI and blood density. Themethod ismore reliable than the invasive techniques.

Nanocurcumin improved glucose metabolism in streptozotocin-induced diabetic rats: a comparison study with Gliclazide.

In the present study, the biochemical effect of nanocurcumin (nanoCUR) compared with Gliclazide (GLZ) on the diabetic rats was studied. Forty male albino rats (Sprague Dawley) weighted 110 ± 20g were used. Rats were randomly separated into two groups. Control, received no treatment. Streptozotocin (STZ)-induced diabetic groups take 5ml/kg of STZ in normal saline daily for 30days, further divided into diabetic non-treated group, did not receive any treatment: diabetic group treated by nanoCUR, received 15mg/kg/day of nanoCUR orally for 30days; diabetic group treated by GLZ, received 2mg/kg/day of GLZ for 30days. The mean body weights of all rats were registered and serum samples were collected for determination of fasting blood glucose (FBG), insulin concentration, liver glucokinase (GK), and glycogen synthase (GS) activities. Liver tissues were collected for determination of mRNA expression of insulin (INS), insulin receptor A (IRA), glucokinase (GK), and glucose transporter 2 (GLUT2). The results revealed a significant reduction of body weight in diabetic rats, with no significant differences in nanoCUR and GLZ groups. There was a decline in FBG levels and significant elevation of INS levels, GK, and GS activities in diabetic rats received nanoCUR and GLZ. mRNA expression of INS, IRA, GK, and GLUT2 significantly upregulated in diabetic rats received nanoCUR and GLZ. The amazing observation was a non-significant difference in all measured parameters between nanoCUR and GLZ groups. In conclusion, nanoCUR is able to improve cellular uptake of glucose, the hepatic insulin signaling, and insulin sensitivity in diabetic rats. Its effect was similar to standard hypoglycemic drug (GLZ).

Associations between oxygen delivery and cardiac index with hyperlactatemia during cardiopulmonary bypass.

ObjectiveMetabolism management plays an essential role during cardiopulmonary bypass (CPB). There are different metabolic management devices integrated to heart–lung machines; the most commonly used and accepted metabolic target is indexed oxygen delivery (DO2i) (280 mL/min/m2) and cardiac index (CI) (2.4 L/min/m2), which can be managed independently or according to other metabolic parameters. Our objective was to compare lactate production during CPB procedures using different metabolic management: DO2i in relation to indexed oxygen extraction ratio (O2ERi) and CI in relation to mixed venous oxygen saturation (SvO2).MethodsData on 500 CPB procedures were retrospectively collected in a specialized regional tertiary cardiac surgery center in Italy between September and 2012 and November 2019. In group A, the DO2i with 280 mL/min/m2 target in relation to O2ERi 25% was used; in group B, CI with 2.4 L/min/m2 target in relation to SvO2 75% was used. During CPB, serial arterial blood gas analyses with blood lactate and glucose determinations were obtained. Hyperlactatemia (HL) was defined as a peak arterial blood lactate concentration >3 mmol/L. The postoperative outcome of patients with or without HL was compared.ResultsEight pre- and intraoperative factors were found to be significantly associated with peak blood lactate level during CPB at univariate analysis. HL (>3 mmol/L) was detected in 15 (6%) patients of group A and in 42 (16.8%) patients of group B (P = .022); hyperglycemia (>160 mg/dL) was found in 23 (9.2%) patients of group A and in 53 (21.2%) patients of group B (P = .038). Patients with HL during CPB had a significant increase in serum creatinine value, higher rate of prolonged mechanical ventilation time and intensive care unit stay. A cutoff of DO2i <270 mL/min/m2 in relation to O2ERi >35% in group A and a cutoff of CI <2.4 L/min/m2 in relation to SvO2 <65% in group B were found to have a positive predictive value of 80% and 75% for HL, respectively. A cutoff of DO2i >290 mL/min/m2 in relation to O2ERi 24% in group A and a cutoff of CI >2.4 L/min/m2 in relation to SvO2 >75% in group B were found to have a negative predictive value of 78% and 62% for HL, respectively.ConclusionsThis retrospective observational analysis showed that management of DO2i in relation to O2ERi was 16% more specific in terms of negative predictive value for HL during CPB compared with the use of CI in relation to SvO2. Group A reported a significant reduction in the incidence of intraoperative lactate peak, correlated with postoperative reduction of serum creatinine value, mechanical ventilation time, and intensive care unit stay, compared with group B.

Well-dispersed poly(cysteine)-Ni(OH)2 nanocomposites on graphene-modified electrode surface for highly sensitive non-enzymatic glucose detection

A kind of nickel-based nanomaterial was prepared and its application in the highly sensitive non-enzymatic glucose detection was realized in this article. Cyclic voltammetric scan generated the well-dispersed poly(cysteine)-Ni(OH)2 nanocomposites, which were analyzed by scanning electron microscopy, infrared spectroscopy and X-ray photoelectron spectroscopy, on the grephene-modified electrode surface. In strong alkaline medium, this Ni-based nanomaterial showed a good electrocatalytic activity for the oxidation of glucose. The current change during the chronoamperometric measurement showed a linear dependence on the glucose level from 1.0 μM to 0.10 mM and that from 0.20 mM to 2.0 mM, with a detection limit of 0.35 μM and a sensitivity of 1092 μA mM−1 cm-2. The fast response time, good selectivity, satisfactory reproducibility, excellent repeatability, high stability and the successful application in the determination of blood glucose demonstrated the excellent performance of the fabricated sensor. The analysis on cell lysate reveals the high-glucose medium could induce the enhancement of glucose content in human umbilical vein endothelial cells and this glucose accumulation in these cells was one of important reasons for the cell injury.

Non-Invasive Method of Measuring Blood Sugar in the Early Stage and Diagnose the Result Using Discrete Wavelet Transform

Monitoring of blood glucose levels is clinically crucial in managing diseases affecting insulin secretion and resistance, most notably diabetes mellitus and cystic fibrosis. Blood glucose s used to monitor the amount of glucose in the blood, especially patients with symptoms with the abnormally of high or low blood glucose levels. Most recently, they enable diabetic patients to administer appropriate insulin doses to human health. The availability of in-house glucometers, as opposed to clinical-use equipment, has dramatically improved the quality of life of diabetic’s patient. However, such monitors require a blood draw through finger pricks for each test, which causes pain and inconvenience. Each test also needs a new test-strip, contributing to the recurring cost of such a device. Typically the blood glucose monitoring is the non-invasive technique which may cause distress and discomfort, particularly in the pediatric patient. We introduce an architecture that uses Near Infrared (NIR) spectroscopy to determine blood glucose levels based on transmittance spectroscopy on the nose lobe. The Measurement of glucose in the respiratory fluid by a collection of exhaled breath in condensate and therefore, a potentially clinically useful method of estimating blood glucose levels identified and therefore it is the excellent agreement between these diabetics blood glucose level.

Characteristic Analysis of Type 2 Diabetes Mellitus Based on HbA1C

Introduction: Type 2 Diabetes Mellitus (DM) is a group of metabolic diseases with hyperglycemia characteristic that occurs due to insulin resistance accompanied by relative insulin deficiency. Monitoring the metabolic status of DM patients is important. One method that can be used to determine blood glucose control in people with DM is measurement of hemoglobin-glycosylated (HbA1c). Objective: The purpose of this study is to determine the characteristics of DM patients based on HbA1c levels in Ponorogo Regency, East Java, Indonesia. Method: The study used a cross-sectional design, and descriptive data presentation. The study took a sample of 180 people with type 2 diabetes in Ponorogo Regency. Respondent characteristic data in the form of age, sex, education and duration of DM were obtained through interviews, and HbA1c values were obtained by blood tests in a standardized laboratory in Ponorogo Regency. Results: The results of the study shows that 81.7% of 180 DM patients had 16.5% HbA1c values. Patients with HbA1c ≥6.5% are mostly women, old age, low education, and have had suffered DM less than 5 years. Discussion: To prevent further complications, glycemic control is needed through routine and periodic HbA1c checks.

Effect of garden cress in reducing blood glucose, improving blood lipids, and reducing oxidative stress in a mouse model of diabetes induced by a high-fat diet and streptozotocin.

A mouse model in which diabetes mellitus was induced by low-dose streptozotocin (STZ) injection combined with a high-fat diet was used to study the effect of two water cress (Lepidium savitum) preparations. Diabetic mice were treated with dried cress powder or with water-soluble extracts (tested at two doses), together with proper control groups. The mice were evaluated after 4 weeks of continuous intervention for type 2 diabetic and associated markers. We determined blood glucose, body weight, total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), serum insulin levels, and DNA integrity of hepatic cells. The concentrations of malondialdehyde (MDA) and lipid peroxide (LPO) and the activities of four enzymes that are part of the antioxidant defense system were determined in liver samples, as well as gene expression (by semi-quantitative reverse transcription polymerase chain reaction) and enzyme activity of IRS-1, IRS-2, PI3K, AKT-2, and GLUT4. After 4 weeks of intervention, the levels of TC, TG, and LDL cholesterol were significantly (P < 0.5) decreased and HDL cholesterol was significantly increased. Enzyme activities of liver superoxide dismutase, glutathione, glutathione peroxidase, and catalase were significantly increased, whereas MDA and LPO concentrations were significantly reduced. The transcription level of the five genes assessed was increased, with corresponding increases in protein expression. Oral uptake of garden cress can significantly reduce the blood glucose and improve the blood lipid metabolism of diabetic mice. Considerable improvements in the activity of antioxidant defense enzymes were observed in type 2 diabetic mice that improved the body's antioxidant emergency response. © 2019 Society of Chemical Industry.

A graphite pencil electrode with electrodeposited Pt-CuO for nonenzymatic amperometric sensing of glucose over a wide linear response range.

A disposable nonenzymatic glucose sensor was obtained by pulsed electrodeposition of Pt-CuO on a graphite pencil electrode (GPE). The morphology of the modified GPE was studied using SEM, and the chemical composition of the coating was examined by EDAX and XRD. The electrochemical response of the modified GPE was compared with individual copper- and platinum-modified GPEs. The electrodeposition parameters were optimized with respect to the electrocatalytic activity of the deposits towards glucose oxidation. Best operated at a working potential of 0.6V vs. Ag/AgCl, the sensor has a sensitivity of 2035μAmM-1cm-2, a 0.1μM detection limit and a wide linear response range that extends up to 25mM. It is highly selective for glucose in the presence of various exogenous and endogenous interfering species. Eventhough the requirement of alkaline medium for sensing is a limitation, easy fabrication procedure, very high sensitivity and selectivity, wide analytical range, and disposable sensor characteristics show potential application towards blood glucose determination. Graphical abstractSchematic representation of the Pt-CuO electrodeposited pencil graphite electrode for the nonenzymatic determination of glucose.

Correlation between serum 25-OH vitamin D expression and non-alcoholic fatty liver disease.

This study investigated changes in the level of serum 25-OH vitamin D [25-hydroxyvitamin D, 25(OH)D] in patients with non-alcoholic fatty liver disease (NAFLD) and the correlation between the severity of NAFLD and 25(OH)D. A retrospective analysis was performed on 385 NAFLD patients (NAFLD group) admitted to the Zhongshan Hospital Affiliated to Xiamen University from January 2015 to December 2017 and 347 healthy people with physical examination (control group). The height and weight of all subjects were measured, and BMI was calculated. Fasting venous blood was extracted for the determination of blood glucose, blood lipid and 25(OH)D. The indicator levels of patients in the two groups were compared and analyzed. Spearman's correlation analysis was used to investigate the correlation between the severity of NAFLD and the level of 25(OH)D. The levels of BMI, FPG, FPI, HbA1c, TG, TC and LDL-C of patients in the NAFLD group were significantly higher than those in control group (P<0.05). The level of 25(OH)D in the NAFLD group was lower than that in control group (P<0.05). There was a significant negative correlation between 25(OH)D and the severity of patients in the NAFLD group (r=−0.868, P<0.001). BMI, FPG, FPI, HbA1c, TG, TC and LDL-C were independent risk factors for the low level of 25(OH)D (P<0.05). Lowly expressed in the serum of NAFLD patients, 25(OH)D has a significant negative correlation with the severity of NAFLD, which is of guiding significance for the prevention and treatment. 25(OH)D is a novel biomarker for NAFLD diagnosis and a potential drug target.